1. Home
  2. DOMO vs DCTH Comparison

DOMO vs DCTH Comparison

Compare DOMO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • DCTH
  • Stock Information
  • Founded
  • DOMO 2010
  • DCTH 1988
  • Country
  • DOMO United States
  • DCTH United States
  • Employees
  • DOMO N/A
  • DCTH N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • DCTH Medical/Dental Instruments
  • Sector
  • DOMO Technology
  • DCTH Health Care
  • Exchange
  • DOMO Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • DOMO 436.2M
  • DCTH 485.5M
  • IPO Year
  • DOMO 2018
  • DCTH N/A
  • Fundamental
  • Price
  • DOMO $14.82
  • DCTH $12.69
  • Analyst Decision
  • DOMO Hold
  • DCTH Strong Buy
  • Analyst Count
  • DOMO 6
  • DCTH 4
  • Target Price
  • DOMO $12.17
  • DCTH $24.00
  • AVG Volume (30 Days)
  • DOMO 688.9K
  • DCTH 777.8K
  • Earning Date
  • DOMO 08-28-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • DOMO N/A
  • DCTH N/A
  • EPS Growth
  • DOMO N/A
  • DCTH N/A
  • EPS
  • DOMO N/A
  • DCTH N/A
  • Revenue
  • DOMO $317,052,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • DOMO $1.71
  • DCTH $155.42
  • Revenue Next Year
  • DOMO $2.43
  • DCTH $37.93
  • P/E Ratio
  • DOMO N/A
  • DCTH N/A
  • Revenue Growth
  • DOMO N/A
  • DCTH 1068.87
  • 52 Week Low
  • DOMO $6.01
  • DCTH $7.17
  • 52 Week High
  • DOMO $15.09
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 67.51
  • DCTH 33.81
  • Support Level
  • DOMO $13.54
  • DCTH $13.30
  • Resistance Level
  • DOMO $14.82
  • DCTH $14.15
  • Average True Range (ATR)
  • DOMO 0.73
  • DCTH 0.64
  • MACD
  • DOMO -0.01
  • DCTH -0.26
  • Stochastic Oscillator
  • DOMO 94.04
  • DCTH 8.28

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: